LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
83 hedge funds and large institutions have $286M invested in La Jolla Pharmaceutical Company in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
57% less capital invested
Capital invested by funds: $670M → $286M (-$384M)
Holders
83
Holding in Top 10
2
Calls
$389K
Puts
$374K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$2.99M | |
| 3 | +$1.2M | |
| 4 |
SIM
Spark Investment Management
New York
|
+$1.16M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.04M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$8.76M | |
| 3 | -$4.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.44M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.52M |